methylprednisolone hemisuccinate has been researched along with Allergic Encephalomyelitis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allon, N; Barenholz, Y; Bavli, Y; Katzir, TB; Kizelsztein, P; Ovadia, H; Raviv, U; Sasson, E; Schilt, Y; Turjeman, K | 1 |
Avnir, Y; Barenholz, Y; Gabizon, A; Kizelsztein, P; Sigal, A; Tulchinsky, D; Turjeman, K; Tzemach, D | 1 |
Hall, ED; Karlik, SJ; Stavraky, RT | 1 |
3 other study(ies) available for methylprednisolone hemisuccinate and Allergic Encephalomyelitis
Article | Year |
---|---|
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
Topics: Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Apolipoproteins E; Cyclic N-Oxides; Disease Models, Animal; Drug Delivery Systems; Encephalomyelitis, Autoimmune, Experimental; Inflammation; Liposomes; Methylprednisolone Hemisuccinate; Mice; Multiple Sclerosis; Nanoparticles; Neurodegenerative Diseases; Prodrugs; Tissue Distribution | 2015 |
Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids.
Topics: Animals; Capsules; Chemical Phenomena; Chemistry, Pharmaceutical; Encephalomyelitis, Autoimmune, Experimental; Female; Glucocorticoids; Humans; Hydrophobic and Hydrophilic Interactions; Leukemia; Liposomes; Lymphoma, T-Cell; Methylprednisolone Hemisuccinate; Mice; Multiple Sclerosis; Myelin Proteolipid Protein; Nanostructures; Solubility; Water | 2011 |
Comparison of tirilazad mesylate (U-74006F) and methylprednisolone sodium succinate treatments in experimental allergic encephalomyelitis in the guinea pig.
Topics: Acute Disease; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Guinea Pigs; Methylprednisolone Hemisuccinate; Neuroprotective Agents; Pregnatrienes; Reference Values; Treatment Outcome | 1996 |